Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans

Pain

Volumn 147, Issue 1-3, 2009, Pages 187-193

  Treister, Roi ^a,b   Pud, Dorit ^b,c   Ebstein, Richard P ^d   Laiba, Efrat ^d   Gershon, Edith ^b   Haddad, May ^e   Eisenberg, Elon ^a,b,e  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Pain Research Group   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

^d HERZOG HOSPITAL   (Israel)

^e RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Cold pressor test (CPT); Dopamine transporter; Experimental pain; Genetics; Monoamine oxidase A

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; NEUROTRANSMITTER;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; COLD EXPOSURE; COLD TOLERANCE; DAT 1 GENE; DNA DETERMINATION; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; DRD4 GENE; EXON; FEMALE; FIBROMYALGIA; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEADACHE; HEAT TOLERANCE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MALE; MAO A GENE; NOCICEPTION; NORMAL HUMAN; PAIN; PAIN ASSESSMENT; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; THERMAL EXPOSURE; TRANSMISSION DISEQUILIBRIUM TEST; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; COLD TEMPERATURE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; HYPERALGESIA; JEWS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MONOAMINE OXIDASE; PAIN MEASUREMENT; PAIN THRESHOLD; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D4; YOUNG ADULT;

EID: 70449687891     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.09.001     Document Type: Article

References (55)

1. Altier N., and Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65 (1999) 2269-2287
2. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., and Van Tol H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65 (1995) 1157-1165
3. Brefel-Courbon C., Payoux P., Thalamas C., Ory F., Quelven I., Chollet F., Montastruc J.L., and Rascol O. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 20 (2005) 1557-1563
4. Burkey A.R., Carstens E., and Jasmine L. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci 19 (1999) 4169-4179
5. Buskila D., Cohen H., Neumann L., and Ebstein R.P. An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 9 (2004) 730-731
6. Cevoli S., Mochi M., Scapoli C., Marzocchi N., Pierangeli G., Pini L.A., Cortelli P., and Montagna P. A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13 (2006) 1009-1013
7. Chen A.L., Chen T.J., Waite R.L., Reinking J., Tung H.L., Rhoades P., Downs B.W., Braverman E., Braverman D., Kerner M., Blum S.H., Dinubile N., Smith D., Oscar-Berman M., Prihoda T.J., Floyd J.B., O'Brien D., Liu H.H., and Blum K. Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions. Med Hypotheses 72 (2009) 14-22
8. Chen K., Holschneider D.P., Wu W., Rebrin I., and Shih J.C.A. Spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J Biol Chem 279 (2004) 39645-39652
9. Chen Z.Y., Powell J.F., Hsu Y.P., Breakefield X.O., and Craig I.W. Organization of the human monoamine oxidase genes and long-range physical mapping around them. Genomics 14 (1992) 75-82
10. Cheon K.A., Ryu Y.H., Kim J.W., and Cho D.Y. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur Neuropsychopharmacol 15 (2005) 95-101
11. Coffeen U., López-Avila A., Ortega-Legaspi J.M., del Angel R., López-Muñoz F.J., and Pellicer F. Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat. Eur J Pain 12 (2008) 535-543
12. Diatchenko L., Slade G.D., Nackley A.G., Bhalang K., Sigurdsson A., Belfer I., Goldman D., Xu K., Shabalina S.A., Shagin D., Max M.B., Makarov S.S., and Maixner W. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14 (2005) 135-143
13. Diatchenko L., Nackley A.G., Slade G.D., Bhalang K., Belfer I., Max M.B., Goldman D., and Maixner W. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 125 (2006) 216-224
14. Dickey R.P., and Minton J.P. Levodopa relief of bone pain from breast cancer. N Engl J Med 286 (1972) 843
15. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115-121
16. Edwards R.R. Genetic predictors of acute and chronic pain. Curr Rheumatol Rep 8 (2006) 411-417
17. Ertas M., Sagduyu A., Arac N., Uludag B., and Ertekin C. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 75 (1998) 257-259
18. Fejer R., Hartvigsen J., and Kyvik K.O. Heritability of neck pain: a population-based study of 33,794 Danish twins. Rheumatology (Oxford) 45 (2006) 589-594
19. Fields H.L., and Basbaum A.I. Central nervous system mechanisms of pain modulation. In: Wall P.D., and Melzack R. (Eds). Textbook of pain. 4th ed. (1999), Churchill Livingstone, Edinburgh 309-330
20. Flores J.A., El Banoua F., Galán-Rodríguez B., and Fernandez-Espejo E. Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain 110 (2004) 205-214
21. Foulkes T., and Wood J.N. Pain genes. PLoS Genet 4 7 (2008) e1000086
22. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., and Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1 (2001) 152-156
23. George S.Z., Wallace M.R., Wright T.W., Moser M.W., Greenfield III W.H., Sack B.K., Herbstman D.M., and Fillingim R.B. Evidence for a biopsychosocial influence on shoulder pain: pain catastrophizing and catechol-O-methyltransferase (COMT) diplotype predict clinical pain ratings. Pain 136 (2008) 53-61
24. Gerdelat-Mas A., Simonetta-Moreau M., Thalamas C., Ory-Magne F., Slaoui T., Rascol O., and Brefel-Courbon C. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J Neurol Neurosurg Psychiatry 78 10 (2007) 1140-1142
25. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine receptor. Nature 370 (1996) 606-612
26. Harris G., and Rollman G.B. The validity of experimental pain measures. Pain 17 (1983) 369-376
27. Hestbaek L., Iachine I.A., Leboeuf-Yde C., Kyvik K.O., and Manniche C. Heredity of low back pain in a young population: a classical twin study. Twin Res 7 (2004) 16-26
28. Holman A.J., and Myers R.R. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52 (2005) 2495-2505
29. Jääskeläinen S.K., Rinne J.O., Forssell H., Tenovuo O., Kaasinen V., Sonninen P., and Bergman J. Role of the dopaminergic system in chronic pain a fluorodopa-PET study. Pain 90 (2001) 257-260
30. Kernbaum S., and Hauchecorne J. Administration of levodopa for relief of herpes zoster pain. J Am Med Assoc 246 (1981) 132-134
31. Kim H., Lee H., Rowan J., Brahim J., and Dionne R.A. Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans. Mol Pain 2 (2006) 24
32. Lee M.A., Walker R.W., Hildreth T.J., and Prentice W.M. A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manage 32 (2006) 462-469
33. Lindvall O., Bjorklund A., and Skagerberg G. Dopamine containing neurons in the spinal cord: anatomy and some functional aspects. Ann Neurol 14 (1983) 255-260
34. Lötsch J., and Geisslinger G. Current evidence for a modulation of nociception by human genetic polymorphisms. Pain 132 (2007) 18-22
35. Meyer P.J., Morgan M.M., Kozell L.B., and Ingram S.L. Contribution of dopamine receptors to periaqueductal gray-mediated antinociception. Psychopharmacology (Berl) 204 (2009) 531-540
36. Mulder E.J., Van Baal C., Gaist D., Kallela M., Kaprio J., Svensson D.A., Nyholt D.R., Martin N.G., MacGregor A.J., Cherkas L.F., Boomsma D.I., and Palotie A. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res 6 (2003) 422-431
37. NCI-NHGRI Working Group on Replication in Association Studies, Chanock S.J., Manolio T., Boehnke M., Boerwinkle E., Hunter D.J., Thomas G., Hirschhorn J.N., Abecasis G., Altshuler D., Bailey-Wilson J.E., Brooks L.D., Cardon L.R., Daly M., Donnelly P., Fraumeni Jr. J.F., Freimer N.B., Gerhard D.S., Gunter C., Guttmacher A.E., Guyer M.S., Harris E.L., Hoh J., Hoover R., Kong C.A., Merikangas K.R., Morton C.C., Palmer L.J., Phimister E.G., Rice J.P., Roberts J., Rotimi C., Tucker M.A., Vogan K.J., Wacholder S., Wijsman E.M., Winn D.M., and Collins F.S. Replicating genotype-phenotype associations. Nature 447 (2007) 655-660
38. Nielsen C.S., Stubhaug A., Price D.D., Vassend O., Czajkowski N., and Harris J.R. Individual differences in pain sensitivity: genetic and environmental contributions. Pain 136 (2008) 21-29
39. Nixon D.W. Letter: use of L-dopa to relieve pain from bone metastases. N Engl J Med 292 (1975) 647
40. Norbury T.A., MacGregor A.J., Urwin J., Spector T.D., and McMahon S.B. Heritability of responses to painful stimuli in women: a classical twin study. Brain 130 (2007) 3041-3049
41. Oldenhof J., Vickery R., Anafi M., Oak J., Ray A., Schoots O., Pawson T., von Zastrow M., and Van Tol H.H. SH3-binding domains in the dopamine D4 receptor. Biochemistry 37 (1998) 15726-15736
42. Sabol S.Z., Hu S., and Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103 (1998) 273-279
43. Slaoui T., Mas-Gerdelat A., Ory-Magne F., Rascol O., and Brefel-Courbon C. Levodopa modifies pain thresholds in Parkinson's disease patients. Rev Neurol (Paris) 163 (2007) 66-71
44. Tinazzi M., Del Vesco C., Fincati E., Ottaviani S., Smania N., Moretto G., Fiaschi A., Martino D., and Defazio G. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 77 (2006) 822-825
45. Vandenbergh D.J., Persico A.M., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., and Uhl G.R. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14 (1992) 1104-1106
46. Vandenbergh D.J., Persico A.M., and Uhl G.R. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Mol Brain Res 15 (1992) 161-166
47. Van Dyck C.H., Malison R.T., Jacobsen L.K., Seibyl J.P., Staley J.K., Laruelle M., Baldwin R.M., Innis R.B., and Gelernter J. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46 (2005) 745-751
48. Van Tol H.H., Wu C.M., Guan H.C., Ohara K., Bunzow J.R., Civelli O., Kennedy J., Seeman P., Niznik H.B., and Jovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature 358 (1992) 149-152
49. Wallace M., Schulteis G., Atkinson J.H., Wolfson T., Lazzaretto D., Bentley H., Gouaux B., and Abramson I. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology 107 (2007) 785-796
50. Wood P.B., Schweinhardt P., Jaeger E., Dagher A., Hakyemez H., Rabiner E.A., Bushnell M.C., and Chizh B.A. Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25 (2007) 3576-3582
51. Wood P.B. Role of central dopamine in pain and analgesia. Expert Rev Neurother 8 (2008) 781-797
52. Schestatsky P., Kumru H., Valls-Solé J., Valldeoriola F., Marti M.J., Tolosa E., and Chaves M.L. Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 69 (2007) 2162-2169
53. Shyu B.C., Kiritsy-Roy J.A., Morrow T.J., and Casey K.L. Neurophysiological, pharmacological and behavioral evidence for medial thalamic mediation of cocaine-induced dopaminergic analgesia. Brain Res 572 (1992) 216-223
54. Zayats T., Young T.L., Mackey D.A., Malecaze F., Calvas P., and Guggenheim J.A. Quality of DNA extracted from mouthwashes. PLoS One 7;4 (2009) e6165
55. Zubieta J.K., Heitzeg M.M., Smith Y.R., Bueller J.A., Xu K., Xu Y., Koeppe R.A., Stohler C.S., and Goldman D. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299 (2003) 1240-1243